Ara mostrant els elements 1-1 de 1
Sampera Borràs, Aïda (Data de defensa: 2018-11-20)
The HER2 receptor is overexpressed in 7-34% of gastric cancer (GC) tumors, being a potential therapeutic target. Trastuzumab, an anti-HER2 monoclonal antibody, in combination with platinum therapy was approved in 2010 as ...